Other Meetings/Courses

2021 McGill Pharmacoepidemiology Virtual Summer Program 

This year we will offer the first two levels of pharmacoepidemiology courses virtually, each given intensively over a 1 or 2 week period and taught by skilled pharmacoepidemiologists and talented instructors as well as two novel specialized courses, to complement the traditional offerings in pharmacoepidemiology (see below). Please note below the courses that will not be offered in 2021.

May 10th-May 21st: Introduction to Pharmacoepidemiology (Dr. Christel Renoux)  
May 31st-June 11th: Intermediate Pharmacoepidemiology (Drs Laurent Azoulay and Kristian Filion)
May 25th-May 28th: Confounding Control in Pharmacepidemiology (Dr. Robert Platt)
June 14th-June 18th: Pharmacoeconomics for Health Technology Assessment (Dr. Jaime Caro)

  • Advanced Pharmacoepidemiology (Drs Samy Suissa and Antonios Douros)
  • Digital Pharmacoepidemiology (Dr. David Buckeridge)

View flyer here

Register here

Questions? Contact Marisa Mancini (

London School of Hygiene & Tropical Medicine COVID-19 Course

Pharmacoepidemiology in the era of COVID-19 short course @ LSHTM – open for applications!

The Electronic Health Records (EHR) Research Group at the London School of Hygiene & Tropical Medicine are pleased to announce a brand new online short course on COVID-19 pharmacoepidemiology research, entitled “Pharmacoepidemiology in the era of COVID-19: How to interpret research into the effects of medicines.”

During the COVID-19 pandemic, there has been unprecedented interest in the performance of medicines. This four-day course will introduce the study designs, data sources, and methods used to investigate whether a number of already licensed and widely used medicines are effective in preventing or treating COVID-19 and introduce the skills necessary to evaluate and interpret the findings, as reported in both scientific journals and the media.

Course dates: 22-25 March 2021

Course delivery: Online via Zoom

Fees: £250 full fee, £125 students, £50 LMIC

*Applications close 22 February*

There are no formal pre-requisites for this course, but some scientific or medical background would be beneficial. 

By the end of the course, students will be able to:

  1. Understand key concepts of pharmacoepidemiology with a focus on studies related to COVID-19
  2. Understand how to critically appraise published trials and observational studies evaluating medicines for the prevention and treatment of COVID-19
  3. Understand how vaccines for COVID-19 have been developed and how their safety and efficacy will be assessed

Click here for further details and how to apply. Anyone with questions about the course content/suitability can contact Christopher Rentsch ( or Anna Schultze (